Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Hepatitis C

  Free Subscription


Articles published in Am J Gastroenterol

Retrieve available abstracts of 18 articles:
HTML format
Text format



Single Articles


    April 2017
  1. LEE MH, Hsiao TI, Subramaniam SR, Le AK, et al
    HCV Genotype 6 Increased the Risk for Hepatocellular Carcinoma Among Asian Patients With Liver Cirrhosis.
    Am J Gastroenterol. 2017 Apr 25. doi: 10.1038/ajg.2017.
    PubMed     Text format     Abstract available


  2. OOKA K, Connolly JJ, Lim JK
    Medicaid Reimbursement for Oral Direct Antiviral Agents for the Treatment of Chronic Hepatitis C.
    Am J Gastroenterol. 2017 Apr 4. doi: 10.1038/ajg.2017.
    PubMed     Text format    


    February 2017
  3. TAKYAR V, Kleiner DE, Koh C
    A Wolf in Sheep's Clothing in the Era of Non-Invasive Staging: Non-Hodgkin's Lymphoma Masquerading as Serologic HCV Cirrhosis.
    Am J Gastroenterol. 2017;112:398-399.
    PubMed     Text format    


  4. YANG JD, Mohamed HA, Cvinar JL, Gores GJ, et al
    Corrigendum: Diabetes Mellitus Heightens the Risk of Hepatocellular Carcinoma Except in Patients With Hepatitis C Cirrhosis.
    Am J Gastroenterol. 2017;112:402.
    PubMed     Text format    


    December 2016
  5. PILLAI AA, Anania FA, Pearlman BL
    Caution: Reactivation of Hepatitis B during Hepatitis C Treatment with Direct-Acting Antiviral Therapy.
    Am J Gastroenterol. 2016;111:1854-1856.
    PubMed     Text format    


    August 2016
  6. YANG JD, Mohamed HA, Cvinar JL, Gores GJ, et al
    Diabetes Mellitus Heightens the Risk of Hepatocellular Carcinoma Except in Patients With Hepatitis C Cirrhosis.
    Am J Gastroenterol. 2016 Aug 16. doi: 10.1038/ajg.2016.
    PubMed     Text format     Abstract available


    July 2016
  7. SHIFFMAN ML, Rustgi V, Bennett M, Forns X, et al
    Corrigendum: Safety and Efficacy of Ombitasvir/Paritaprevir/Ritonavir Plus Dasabuvir With or Without Ribavirin in HCV-Infected Patients Taking Concomitant Acid-Reducing Agents.
    Am J Gastroenterol. 2016;111:1077.
    PubMed     Text format    


    June 2016
  8. SCHITZ A, Moser S, Marchart K, Haltmayer H, et al
    Direct Observed Therapy of Chronic Hepatitis C With Interferon-Free All-Oral Regimens at a Low-Threshold Drug Treatment Facility-a New Concept for Treatment of Patients With Borderline Compliance Receiving Opioid Substitution Therapy.
    Am J Gastroenterol. 2016;111:903-5.
    PubMed     Text format    


    May 2016
  9. STERN R, Hametner S, Ramona AZ, Moser S, et al
    Interferon/Ribavirin-Free Antiviral Treatment in Septuagenarians and Octogenarians With Chronic Hepatitis C.
    Am J Gastroenterol. 2016;111:744-5.
    PubMed     Text format    


    April 2016
  10. SHIFFMAN ML, Rustgi V, Bennett M, Forns X, et al
    Safety and Efficacy of Ombitasvir/Paritaprevir/Ritonavir Plus Dasabuvir With or Without Ribavirin in HCV-Infected Patients Taking Concomitant Acid-Reducing Agents.
    Am J Gastroenterol. 2016 Apr 5. doi: 10.1038/ajg.2016.
    PubMed     Text format     Abstract available


    March 2016
  11. YOUNOSSI ZM, Stepanova M, Henry L, Nader F, et al
    An In-Depth Analysis of Patient-Reported Outcomes in Patients With Chronic Hepatitis C Treated With Different Anti-Viral Regimens.
    Am J Gastroenterol. 2016 Mar 29. doi: 10.1038/ajg.2016.
    PubMed     Text format     Abstract available


  12. SHI Y, Xia F, Li QJ, Li JH, et al
    Magnetic Resonance Elastography for the Evaluation of Liver Fibrosis in Chronic Hepatitis B and C by Using Both Gradient-Recalled Echo and Spin-Echo Echo Planar Imaging: A Prospective Study.
    Am J Gastroenterol. 2016 Mar 15. doi: 10.1038/ajg.2016.
    PubMed     Text format     Abstract available


  13. LIU KL, Shih IL, Huang YC, Chen CH, et al
    Image of the Month: Abdominoscrotal Hydrocele.
    Am J Gastroenterol. 2016;111:312.
    PubMed     Text format    


    February 2016
  14. PILLAI AA, Wedd J, Norvell JP, Parekh S, et al
    Simeprevir and Sofosbuvir (SMV-SOF) for 12 Weeks for the Treatment of Chronic Hepatitis C Genotype 1 Infection: A Real World (Transplant) Hepatology Practice Experience.
    Am J Gastroenterol. 2016 Feb 2. doi: 10.1038/ajg.2015.
    PubMed     Text format     Abstract available


  15. TRAN TT, Ahn J, Reau NS
    ACG Clinical Guideline: Liver Disease and Pregnancy.
    Am J Gastroenterol. 2016;111:176-94.
    PubMed     Text format     Abstract available


    November 2015
  16. YANG JD, Gyedu A, Afihene MY, Duduyemi BM, et al
    Hepatocellular Carcinoma Occurs at an Earlier Age in Africans, Particularly in Association With Chronic Hepatitis B.
    Am J Gastroenterol. 2015;110:1629-31.
    PubMed     Text format    


    July 2015
  17. SHIFFMAN ML, James AM, Long AG, Alexander PC, et al
    Treatment of Chronic HCV With Sofosbuvir and Simeprevir in Patients With Cirrhosis and Contraindications to Interferon and/or Ribavirin.
    Am J Gastroenterol. 2015 Jul 28. doi: 10.1038/ajg.2015.
    PubMed     Text format     Abstract available


  18. GORDON SC, Lamerato LE, Rupp LB, Holmberg SD, et al
    Prevalence of Cirrhosis in Hepatitis C Patients in the Chronic Hepatitis Cohort Study (CHeCS): A Retrospective and Prospective Observational Study.
    Am J Gastroenterol. 2015 Jul 28. doi: 10.1038/ajg.2015.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Hepatitis C is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: